Practo raises $90 ( Rs 573-crore) million in series C funding
Advertisement
This successful round of Series-C funding by Practo led by Tencent will help the company to focus on expanding the product line, look for potential acquisitions, and increase its manpower
Healthcare platform Practo has recently attracted a $90 million in Series C funding investment by different investors, lead by Tencent, with participation from Sofina, Sequoia India, Google Capital, Altimeter Capital, Matrix Partners, Sequoia Capital Global Equities and Yuri Milner. The money will be churned further for expanding the product capabilities, seeking potential acquisitions, and suiting the manpower requirement of the company in the due course of time.
In next 3-6 months, the company’s focus areas for expansion include medicine, wellness and fitness, globally. Practo today enjoys presence in 35 Indian cities and three countries, and is focused to increase its presence to over 100 Indian cities and 10 countries across South East Asia, Latin America, the Middle East and Eastern Europe. The focus area of operations is to expand business in the diagnostic market.
Healthcare platform Practo has recently attracted a $90 million in Series C funding investment by different investors, lead by Tencent, with participation from Sofina, Sequoia India, Google Capital, Altimeter Capital, Matrix Partners, Sequoia Capital Global Equities and Yuri Milner. The money will be churned further for expanding the product capabilities, seeking potential acquisitions, and suiting the manpower requirement of the company in the due course of time.
In next 3-6 months, the company’s focus areas for expansion include medicine, wellness and fitness, globally. Practo today enjoys presence in 35 Indian cities and three countries, and is focused to increase its presence to over 100 Indian cities and 10 countries across South East Asia, Latin America, the Middle East and Eastern Europe. The focus area of operations is to expand business in the diagnostic market.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.